U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1061-1G>T AND Hypercholesterolemia, familial, 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 24, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001450048.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1061-1G>T]

NM_000527.5(LDLR):c.1061-1G>T

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1061-1G>T
HGVS:
  • NC_000019.10:g.11111513G>T
  • NG_009060.1:g.27133G>T
  • NM_000527.5:c.1061-1G>TMANE SELECT
  • NM_001195798.2:c.1061-1G>T
  • NM_001195799.2:c.938-1G>T
  • NM_001195800.2:c.557-1G>T
  • NM_001195803.2:c.680-1G>T
  • LRG_274t1:c.1061-1G>T
  • LRG_274:g.27133G>T
  • NC_000019.9:g.11222189G>T
  • NM_000527.4:c.1061-1G>T
  • p.(?)
Links:
dbSNP: rs879254774
NCBI 1000 Genomes Browser:
rs879254774
Molecular consequence:
  • NM_000527.5:c.1061-1G>T - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001195798.2:c.1061-1G>T - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001195799.2:c.938-1G>T - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001195800.2:c.557-1G>T - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001195803.2:c.680-1G>T - splice acceptor variant - [Sequence Ontology: SO:0001574]
Observations:
1

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001653619Laboratory of molecular diagnosis of dyslipidemias, Università egli studi di Napoli Federico II
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 24, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
Caucasiangermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.

Pirillo A, Garlaschelli K, Arca M, Averna M, Bertolini S, Calandra S, Tarugi P, Catapano AL; LIPIGEN Group..

Atheroscler Suppl. 2017 Oct;29:17-24. doi: 10.1016/j.atherosclerosissup.2017.07.002.

PubMed [citation]
PMID:
28965616

Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio.

Di Taranto MD, de Falco R, Guardamagna O, Massini G, Giacobbe C, Auricchio R, Malamisura B, Proto M, Palma D, Greco L, Fortunato G.

Clin Chem Lab Med. 2019 Jun 26;57(7):1102-1110. doi: 10.1515/cclm-2018-1037.

PubMed [citation]
PMID:
30710474
See all PubMed Citations (3)

Details of each submission

From Laboratory of molecular diagnosis of dyslipidemias, Università egli studi di Napoli Federico II, SCV001653619.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Caucasian1not providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Jun 23, 2024